Get the Stockscreener App
26.16
1.45%
-0.385
Septerna Inc stock is traded at $26.16, with a volume of 144.34K.
It is down -1.45% in the last 24 hours and up +34.46% over the past month.
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
See More
Previous Close:
$26.55
Open:
$26.4
24h Volume:
144.34K
Relative Volume:
0.44
Market Cap:
$1.17B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-11.52%
1M Performance:
+34.46%
6M Performance:
+162.44%
1Y Performance:
+0.40%
1-Day Range:
$25.74
$26.80
1-Week Range:
$25.46
$29.68
52-Week Range:
$4.17
$29.73
Septerna Inc Stock (SEPN) Company Profile
Name
Septerna Inc
Sector
Industry
Phone
650-338-3533
Address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
26.16 | 1.19B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 117.50B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
722.83 | 76.06B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.56 | 62.53B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
916.31 | 56.75B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
205.04 | 44.10B | 447.02M | -1.18B | -906.14M | -6.1812 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-14-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jun-23-25 | Initiated | H.C. Wainwright | Buy |
| Feb-18-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-19-24 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-19-24 | Initiated | JP Morgan | Overweight |
| Nov-19-24 | Initiated | TD Cowen | Buy |
| Nov-19-24 | Initiated | Wells Fargo | Overweight |
View All
Septerna Inc Stock (SEPN) Latest News
Will Septerna Inc. stock continue dividend increasesJuly 2025 Fed Impact & Smart Money Movement Tracker - Newser
Septerna, Inc. $SEPN Shares Sold by Sio Capital Management LLC - MarketBeat
What hedge fund activity signals for Septerna Inc. stockPortfolio Return Summary & Low Drawdown Momentum Ideas - Newser
Novo Nordisk Inks $2.2B Deal With Septerna: Retail’s Thrilled - MSN
Septerna (SEPN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Can Septerna Inc. stock beat market expectations this quarterQuarterly Performance Summary & Accurate Trade Setup Notifications - Newser
Septerna plunges as safety concerns force an end to early-stage trial - MSN
There is no doubt that Septerna Inc (SEPN) ticks all the boxes. - Setenews
Septerna to Participate in 8th Annual Evercore Healthcare Conference - The Manila Times
Septerna (Nasdaq: SEPN) set for fireside chat at 8th Annual Evercore Healthcare Conference - Stock Titan
Septerna's Novo Partnership Begins To Transform The Story (NASDAQ:SEPN) - Seeking Alpha
Septerna Inc stock hits all-time high at 29.06 USD By Investing.com - Investing.com India
Septerna Inc stock hits all-time high at 29.06 USD - Investing.com
Septerna, Inc. (SEPN) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Septerna (SEPN) Is Up 9.9% After Swinging to Q3 Profit and Revenue Surge – Has the Bull Case Changed? - simplywall.st
Cantor Fitzgerald maintains Overweight rating on Septerna stock at $25 By Investing.com - Investing.com Nigeria
Cantor Fitzgerald maintains Overweight rating on Septerna stock at $25 - Investing.com India
Is Septerna Inc. stock affected by interest rate hikesMarket Performance Recap & Real-Time Volume Surge Alerts - newser.com
What is the fair value of Septerna Inc. stock nowGDP Growth & Reliable Momentum Entry Alerts - newser.com
Statistical indicators supporting Septerna Inc.’s strengthJuly 2025 Chart Watch & Risk Controlled Daily Trade Plans - newser.com
How to recover losses in Septerna Inc. stockMarket Growth Review & Accurate Technical Buy Alerts - newser.com
Will Septerna Inc. stock rally after Fed decisionsTrade Entry Report & Weekly Chart Analysis and Guides - newser.com
Why analysts upgrade Septerna Inc. stockMarket Sentiment Review & Safe Capital Growth Stock Tips - newser.com
Trend analysis for Septerna Inc. this weekShort Setup & Real-Time Volume Triggers - newser.com
Septerna (SEPN) Price Target Increased by 20.29% to 28.22 - MSN
Septerna, Inc.Common Stock (NQ: SEPN - Markets Financial Content
Pattern recognition hints at Septerna Inc. upsideJuly 2025 Drop Watch & Low Drawdown Trading Techniques - newser.com
Why Septerna (SEPN) Is Up 28.5% After Posting a Surprise Profit and Analyst Upgrades - Yahoo Finance
Is Septerna Inc. stock ready for a breakout2025 Momentum Check & Weekly Return Optimization Alerts - newser.com
Wells upgrades Septerna to Overweight on 2026 share catalysts - MSN
How to monitor Septerna Inc. with trend dashboards2025 Market Trends & Growth Focused Stock Pick Reports - newser.com
Is Septerna Inc. stock a defensive play in 20252025 Big Picture & Advanced Swing Trade Entry Plans - newser.com
Septerna (SEPN) Is Up 25.7% After Turning Profitable on Strong Q3 Sales and Analyst Optimism Has The Bull Case Changed? - simplywall.st
A Look at Septerna (SEPN) Valuation Following Strong Q3 Sales and Swing to Profitability - Yahoo Finance
Is Septerna Inc. stock a safe haven assetMarket Risk Report & Real-Time Volume Trigger Notifications - newser.com
Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN), Applied Materials (AMAT) and Nvidia (NVDA) - The Globe and Mail
Septerna Inc Stock (SEPN) Financials Data
There is no financial data for Septerna Inc (SEPN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.10%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):